These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 21824253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of glucagon secretion.
    Young A.
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [Abstract] [Full Text] [Related]

  • 5. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.
    Quesada I, Tudurí E, Ripoll C, Nadal A.
    J Endocrinol; 2008 Oct; 199(1):5-19. PubMed ID: 18669612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.
    Sandoval DA, D'Alessio DA.
    Physiol Rev; 2015 Apr; 95(2):513-48. PubMed ID: 25834231
    [Abstract] [Full Text] [Related]

  • 10. Impact of glucagon-like peptide-1 (7-36) amide, isosteviol and 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside on leucine-mediated α-cell dysfunction.
    Chen X, Hermansen K, Jeppesen PB.
    Diabetes Obes Metab; 2012 Nov; 14(11):1020-31. PubMed ID: 22747908
    [Abstract] [Full Text] [Related]

  • 11. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R, Cui X, Feng J, Gu L, Lang S, Wei T, Yang J, Liu J, Le Y, Wang H, Yang K, Hong T.
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucagon antagonism as a potential therapeutic target in type 2 diabetes.
    Bagger JI, Knop FK, Holst JJ, Vilsbøll T.
    Diabetes Obes Metab; 2011 Nov; 13(11):965-71. PubMed ID: 21615669
    [Abstract] [Full Text] [Related]

  • 14. Metabolic impact of glucagon deficiency.
    Hayashi Y.
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():151-7. PubMed ID: 21824269
    [Abstract] [Full Text] [Related]

  • 15. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
    Dufrane D, Maillart JF, Aouassar N, Goebbels RM, Guiot Y, Gianello P.
    Xenotransplantation; 2009 Oct; 16(3):152-63. PubMed ID: 19566655
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion.
    Bethea M, Bozadjieva-Kramer N, Sandoval DA.
    Endocrinology; 2021 Oct 01; 162(10):. PubMed ID: 34318874
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.